At birth, almost all human peripheral blood CD8(+) T cells express the cost
imulatory molecule CD28, With increasing age, the proportion of CD8(+) T ce
lls that lack CD28 increases. Because the Ag specificity of CD28(-)CD8(+) T
cells has not previously been defined, we studied the contribution of CD28
(-)CD8(+) T cells to the memory CD8(+) CTL response against two human persi
stent viruses, human CMV (HCMV) and HIV. From PBMC of healthy virus carrier
s we, generated multiple independent CTL clones specific for defined viral
peptides and sequenced their TCR beta-chains, We designed clonotypic oligon
ucleotides complementary to each P-chain hypervariable sequence and quantif
ied the size of individual immunodominant CTL clones in PBMC. Some individu
al CTL clones were very large, comprising up to 3.1% of all CD8(+) T cells
in PBMC, and were generally maintained at a stable level for months. Indivi
dual virus-specific CTL clones were consistently more abundant in purified
CD28(-) cells than in the CD8(+) population as a whole. Because CD28(-)CD8(
+) cells as a population have been reported to proliferate poorly in respon
se to mitogen, we studied the function of these virus-specific CD28(-) CTL
clones by quantifying the frequency of peptide-specific CTL precursors usin
g limiting dilution analysis. CD28(-)CD8(+) T cells contained high frequenc
ies of functional memory CTL precursors specific for peptides of HCMV or HI
V, generally higher than in the CD8(+) T cell population as a whole. We con
clude that in asymptomatic HCMV and HIV infection, human CD28(-)CD8(+) T ce
lls contain high frequencies of functional virus-specific memory CTL clones
.